In Glioblastoma, elevated expression of VMP1 was associated with an advanced disease stage, while CRISPR-Cas9-mediated VMP1 depletion inhibited cell proliferation and enhanced cell death [37]. This evidence concerns the gene VMP1 and glioblastoma.